The store will not work correctly when cookies are disabled.
(R)-9-(2,6-difluorophenethyl)-4-ethyl-2-methyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one
ID: ALA4756310
PubChem CID: 162655458
Max Phase: Preclinical
Molecular Formula: C19H26F2N2O2
Molecular Weight: 352.43
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: CCN1CC2(CCN(CCc3c(F)cccc3F)CC2)O[C@H](C)C1=O
Standard InChI: InChI=1S/C19H26F2N2O2/c1-3-23-13-19(25-14(2)18(23)24)8-11-22(12-9-19)10-7-15-16(20)5-4-6-17(15)21/h4-6,14H,3,7-13H2,1-2H3/t14-/m1/s1
Standard InChI Key: YOVPWJVEUHXQCZ-CQSZACIVSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
5.7451 -17.4829 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7410 -18.3001 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4427 -18.7100 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1531 -18.3073 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.1572 -17.4901 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4510 -17.0756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3377 -16.6657 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3377 -17.4829 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.0430 -17.8874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7483 -16.6657 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.0430 -16.2530 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0430 -15.4358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6288 -16.2592 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.8582 -18.7204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5685 -18.3164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2735 -18.7295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2659 -19.5476 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9701 -19.9606 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6814 -19.5566 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6841 -18.7351 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9792 -18.3258 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6316 -17.8930 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9228 -17.4862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9819 -17.5086 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
8.5549 -19.9504 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
7 8 1 0
7 11 1 0
8 9 1 0
9 1 1 0
1 10 1 0
10 11 1 0
11 12 1 1
7 13 2 0
4 14 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
8 22 1 0
22 23 1 0
21 24 1 0
17 25 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 352.43 | Molecular Weight (Monoisotopic): 352.1962 | AlogP: 2.61 | #Rotatable Bonds: 4 |
Polar Surface Area: 32.78 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 7.85 | CX LogP: 2.25 | CX LogD: 1.67 |
Aromatic Rings: 1 | Heavy Atoms: 25 | QED Weighted: 0.84 | Np Likeness Score: -0.63 |
References
1. García M,Virgili M,Alonso M,Alegret C,Farran J,Fernández B,Bordas M,Pascual R,Burgueño J,Vidal-Torres A,Fernández de Henestrosa AR,Ayet E,Merlos M,Vela JM,Plata-Salamán CR,Almansa C. (2020) Discovery of EST73502, a Dual μ-Opioid Receptor Agonist and σ Receptor Antagonist Clinical Candidate for the Treatment of Pain., 63 (24): [PMID:33064947] [10.1021/acs.jmedchem.0c01127] |